With U.S.-China tensions continuing to rise in advance of a second Trump administration, the University of Michigan announced last week that it plans to terminate its two-decade academic collaboration with Shanghai Jiao Tong University in China.
The University of Michigan will be ending its partnership with a Chinese university, following national security concerns and a letter from U.S. Rep. John Moolenaar, R-Mich.,
Mich., sent a warning letter to the University of Michigan about the partnership with the Chinese university from the House Select Committee on the Strategic Competition
The news follows a federal probe that found Chinese University of Michigan students illegally surveilled a military training exercise at Camp Grayling.
The University of Michigan is ending its long-standing partnership with Shanghai Jiao Tong University, becoming the latest major United States research institution to sever ties with a Chinese counterpart under pressure from lawmakers.
A GOP congressman probing China's influence urged the University of Michigan to end its longstanding program with Shanghai Jiao Tong University.
The University of Michigan received a warning letter from Rep. John Moolenaar, R-Mich., last year about its partnership with Shanghai Jiao Tong University.
The University of Michigan acknowledged that letter in announcing ... that too many American universities are collaborating with CCP researchers on critical technologies including weapons ...
University of Michigan Medical School will honor its 175 years of medical education with special events, exhibits.
The content arm of college sports' governing body has Michigan ranked 23rd in their fresh batch of 2025 rankings. NCAA's Stan Becton said Michigan's ranking was the hardest to place of any of the top 25 teams.
The Inclusive History Project, founded in 2022 as an avenue for examining and evaluating the University of Michigan’s history, has created a task force to develop new procedures for the honorific naming of U-M spaces and sites.
A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to before and after surgery. A groundbreaking trial, to test a ...